97 related articles for article (PubMed ID: 3293307)
1. Rarity of tylosin resistance in human pathogenic bacteria.
Lacey RW
Vet Rec; 1988 Apr; 122(18):438-9. PubMed ID: 3293307
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
Andreoni O
Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
[TBL] [Abstract][Full Text] [Related]
3. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
4. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
Knothe H
Infection; 1977; 5(3):137-9. PubMed ID: 914361
[TBL] [Abstract][Full Text] [Related]
5. [Annual changes in susceptibility of clinical isolates to midecamycin acetate].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Aug; 43(8):1341-52. PubMed ID: 2283704
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility studies with josamycin and erythromycin.
Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
Lacey RW
J Clin Pathol; 1977 Jul; 30(7):602-5. PubMed ID: 886013
[TBL] [Abstract][Full Text] [Related]
8. A review of the medical considerations of the use of tylosin and other macrolide antibiotics as additives in animal feeds.
Knothe H
Infection; 1977; 5(3):183-7. PubMed ID: 334674
[TBL] [Abstract][Full Text] [Related]
9. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
Dibb WL; Ragnhildstveit E
NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
[TBL] [Abstract][Full Text] [Related]
10. Resistance pattern and genetics of erythromycin-resistant mutants of Streptococcus pyogenes.
Malke H
J Gen Microbiol; 1970 Dec; 64(3):353-63. PubMed ID: 4930446
[No Abstract] [Full Text] [Related]
11. Rarity of gene transfer between animal and human isolates of Staphylococcus aureus in vitro.
Lacey RW
J Gen Microbiol; 1980 Aug; 119(2):437-42. PubMed ID: 6453205
[TBL] [Abstract][Full Text] [Related]
12. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
Deguchi K
Jpn J Antibiot; 1977 May; 30(5):315-20. PubMed ID: 17021
[TBL] [Abstract][Full Text] [Related]
13. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
Webster C; Ghazanfar K; Slack R
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
[TBL] [Abstract][Full Text] [Related]
14. Studies on the effects of 3-acetyl-4"-isovaleryltylosin against multiple-drug resistant strains of Staphylococcus aureus.
Tsuchiya M; Suzukake K; Hori M; Sawa T; Takeuchi T; Umezawa H; Okamoto R; Nomura H; Tsunekawa H; Inui T
J Antibiot (Tokyo); 1981 Mar; 34(3):305-12. PubMed ID: 7275812
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of rosaramicin with special reference to the risk of resistance.
Lacey RW
J Antimicrob Chemother; 1981 Mar; 7(3):293-9. PubMed ID: 7275879
[No Abstract] [Full Text] [Related]
16. [Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Igari J; Oguri T; Tachibana Y; Misawa N; Nakamura A; Shitara M; Umezu S; Nakamura Y; Tazawa S; Shimoura M; Ugajin K; Mori T; Shimada J; Kaku M; Murase M; Hirakata Y; Matsuda J
Jpn J Antibiot; 1997 Jul; 50(7):640-9. PubMed ID: 9743909
[TBL] [Abstract][Full Text] [Related]
17. [Study on susceptibilities of freshly isolated strains to macrolide antibiotics].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Dec; 43(12):2133-41. PubMed ID: 2086825
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of a novel class of 4'-substituted 16-membered ring macrolides derived from tylosin.
Phan LT; Jian T; Chen Z; Qiu YL; Wang Z; Beach T; Polemeropoulos A; Or YS
J Med Chem; 2004 Jun; 47(12):2965-8. PubMed ID: 15163176
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical studies of rokitamycin in pediatric fields].
Nishimura T; Tabuki K; Aoki S; Takagi M
Jpn J Antibiot; 1988 Jul; 41(7):901-13. PubMed ID: 3050185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
